The meta-analysis of the PIONEER and SUSTAIN trials stated, diarrhoea or dehydration can lead to the increase in blood viscosity, semaglutide increases the risk of deep vein thrombosis possibly due to increasing that of diarrhoea. Similarly, the authors said more research is needed on whether the weight loss often experienced while taking semaglutide drugs may increase the risk of DVT, stating, Moreover, whether an increase in deep vein thrombosis is related to a decrease in body weight also needs to be further investigated. People who are taking Ozempic may have patient-specific risk factors that increase the likelihood of developing blood clots
Pro Tip: Work near a clean surface, not directly over a sink or fan
However, the magnitude of central appetite suppression may differ due to slightly different receptor affinity profiles: Tirzepatide has been engineered for balanced GLP-1/GIP co-agonism Retatrutides GLP-1 affinity is slightly lower, but the energy expenditure component compensates for this In practice, researchers observe that the net caloric deficit achieved with retatrutide is greater even when accounting for the lower GLP-1 affinity, due to the metabolic rate acceleration from glucagon signaling
Parkinson's Disease (PD): GLP-1RAs address central pathological mechanisms in PD, including neuroinflammation, mitochondrial dysfunction, and protein aggregation [27,[33], [34], [35]]